Related Experiment Video
Updated: May 4, 2026

10:12
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Published on: May 15, 2018
9.4K
Whole-Genome Amplification on Single Circulating Trophoblast Cell
Imen Chakchouk1,2, Ignatia B Van den Veyver3,4
1Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|January 1, 2026
Summary
Whole-genome amplification (WGA) enables genetic analysis from single cells. This protocol details WGA for circulating trophoblast cells in cell-based noninvasive prenatal testing (cb-NIPT).
Area of Science:
- Genetics
- Molecular Biology
- Reproductive Medicine
Background:
- Whole-genome amplification (WGA) is crucial for analyzing limited DNA samples, such as single cells.
- Cell-based noninvasive prenatal testing (cb-NIPT) relies on analyzing fetal DNA from maternal blood.
- Existing WGA methods may conflict with single trophoblast isolation protocols.
Purpose of the Study:
- To provide a detailed protocol for WGA on single circulating trophoblast cells.
- To optimize WGA for compatibility with cb-NIPT workflows.
- To facilitate comprehensive genetic analysis from trace amounts of DNA.
Main Methods:
- Isolation of single circulating trophoblast cells from maternal blood.
- Application of a WGA technique compatible with trophoblast isolation steps (fixation, permeabilization, immunostaining).
- SNP genotyping and next-generation sequencing of amplified DNA.
Main Results:
- Successful amplification of the entire genome from isolated single trophoblast cells.
- Generation of sufficient DNA for downstream genetic analysis.
- Demonstration of a viable protocol for cb-NIPT.
Conclusions:
- This protocol enables WGA on single circulating trophoblasts for cb-NIPT.
- The method supports comprehensive genetic testing from trace DNA.
- It addresses compatibility challenges between WGA and cell isolation techniques.
Related Concept Videos
Embryonic Stem Cells
25.8K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
25.8K
Cleavage and Blastulation
42.3K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
42.3K
Embryonic Stem Cells
4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K

